Expression of ABC Transporters is an Unfavorable Prognostic Factor in Laryngeal Squamous Cell Carcinoma

Abstract

Objectives:

Two prominent and well-characterized representatives of adenosine triphosphate–binding cassette (ABC) transporter — Breast cancer resistance protein (BCRP or ABCG2) and P-glycoprotein (P-gp or ABCB1) — Are known to be membrane transporters associated with multidrug resistance. The aim of this study was to explore the correlation between ABC transporter expression and the clinicopathologic characteristics, proliferative index, and apoptotic index and their prognostic value in laryngeal squamous cell carcinoma (LSCC).

Methods:

Paraffin sections of 98 human LSCC specimens were investigated with immunohistochemical techniques. The relationship between ABCG2 and ABCB1 expression and clinicopathologic parameters, proliferative activities, and apoptotic activities and their prognostic value in patients' overall survival rate were subsequently analyzed.

Results:

Immunohistochemical analysis revealed positive expression of ABCG2 and ABCB1 in 52.0% and 41.8% of patients, respectively. There was a positive correlation between ABCG2 expression and ABCB1 expression. The presence of these two proteins was significantly related to clinical stage, lymph node metastasis, and overall survival in LSCC. Interestingly, up-regulation of ABCG2 expression was found to be associated with increased proliferation, but that of ABCB1 was not. Up-regulation of both ABCG2 expression and ABCB1 expression was associated with decreased apoptosis.

Conclusions:

The results of this study revealed that the presence of ABCG2 and/or ABCB1 is predictive for malignant progression and is an independent prognostic factor in LSCC. The mechanism of ABC transporters may contribute to chemotherapy resistance by promoting proliferation and/or suppressing apoptosis.

Keywords

apoptosis breast cancer resistance protein cell proliferation laryngeal squamous cell carcinoma P-glycoprotein prognosis

Get full access to this article

View all access options for this article.

References

Chu

Kim

. Laryngeal cancer: Diagnosis and preoperative work-up. Otolaryngol Clin North Am 2008;41:673–95,v.

Gottesman

Ludwig

Xia

Szakács

. Defeating drug resistance in cancer. Discov Med 2006;6:18–23.

Dean

Hamon

Chimini

. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 2001;42:1007–17.

Borst

Elferink

. Mammalian ABC transporters in health and disease. Annu Rev Biochem 2002;71:537–92.

Doyle

Yang

Abruzzo

. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A 1998;95:15665–70. [Erratum in Proc Natl Acad Sci U S A 1999;96:2569.]

Pai

Westra

. Molecular pathology of head and neck cancer: Implications for diagnosis, prognosis, and treatment. Annu Rev Pathol 2009;4:49–70.

Mizutani

Masuda

Nakai

. Genuine functions of P-glycoprotein (ABCB1). Curr Drug Metab 2008;9:167–74.

Jiang

Dong

Wan

. The characteristics of Hep-2 cell with multiple drug resistance induced by Taxol. Otolaryngol Head Neck Surg 2007;137:659–64.

Smyth

Krasovskis

Sutton

Johnstone

. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis. Proc Natl Acad Sci U S A 1998;95:7024–9.

10.

Takanishi

Miyazaki

Ohtsuka

Nakajima

. Inverse relationship between P-glycoprotein expression and its proliferative activity in hepatocellular carcinoma. Oncology 1997;54:231–7.

11.

Jiang

Dong

Wang

. MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by Taxol. Ann Surg Oncol 2009;16:1421–8.

12.

Gao

Shen

Dong

. Effect of apoptotic and proliferative indices, P-glycoprotein and survivin expression on prognosis in laryngeal squamous cell carcinoma. Med Oncol (in press).

13.

Diestra

Scheffer

Català

. Frequent expression of the multi-drug resistance—associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material. J Pathol 2002;198:213–9.

14.

Shi

Fan

. Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials. J Cancer Res Clin Oncol 2008;134:1155–63.

15.

Wang

Luo

. A side population of cells from a human pancreatic carcinoma cell line harbors cancer stem cell characteristics. Neoplasma 2009;56:371–8.

16.

Yoh

Ishii

Yokose

. Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non—small cell lung cancer. Clin Cancer Res 2004;10:1691–7.

17.

Eckford

Sharom

. ABC efflux pump—based resistance to chemotherapy drugs. Chem Rev 2009;109:2989–3011.

18.

Alvarez

Paull

Monks

. Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen. J Clin Invest 1995;95:2205–14.

19.

Penson

Oliva

Skates

. Expression of multidrug resistance—1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: A study in serial samples. Gynecol Oncol 2004;93:98–106.

20.

Rocchi

Khodjakov

Volk

. The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane. Biochem Biophys Res Commun 2000;271:42–6.

21.

Abbott

Colapietro

Barnes

Marini

Andreeff

Sorrentino

. Low levels of ABCG2 expression in adult AML blast samples. Blood 2002;100:4594–601.

22.

Steinbach

Sell

Voigt

Hermann

Zintl

Sauerbrey

. BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia. Leukemia 2002;16:1443–7.

23.

Sauerbrey

Sell

Steinbach

Voigt

Zintl

. Expression of the BCRP gene (ABCG2/MXR/ABCP) in childhood acute lymphoblastic leukaemia. Br J Haematol 2002;118:147–50.

24.

Plasschaert

van der Kolk

de Bont

. The role of breast cancer resistance protein in acute lymphoblastic leukemia. Clin Cancer Res 2003;9:5171–7.

25.

Benderra

Faussat

Sayada

. Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias. Clin Cancer Res 2004;10:7896–902.

26.

Nakayama

Kanzaki

Ogawa

Miyazaki

Neamati

Takebayashi

. Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: Comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP. Int J Cancer 2002;101:488–95.

27.

Faneyte

Kristel

Maliepaard

. Expression of the breast cancer resistance protein in breast cancer. Clin Cancer Res 2002;8:1068–74.

28.

Tsunoda

Okumura

Ito

. ABCG2 expression is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma. Oncology 2006;71:251–8.

29.

Gottesman

Fojo

Bates

. Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat Rev Cancer 2002;2:48–58.

30.

Hipfner

Cohen

. Connecting proliferation and apoptosis in development and disease. Nat Rev Mol Cell Biol 2004;5:805–15.

31.

Teppo

Soini

Melkko

Koivunen

Alho

. Prognostic factors in laryngeal carcinoma: The role of apoptosis, p53, proliferation (Ki-67) and angiogenesis. APMIS 2003;111:451–7.